Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Completed · Phase 3 · Has a placebo group
Conditions studied: Uterine Fibroids, Heavy Menstrual Bleeding
In brief
The primary objective of this study is to demonstrate the superior efficacy versus placebo of OBE2109 alone and in combination with add-back therapy for the reduction of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Key facts
- Study ID
- NCT03070899
- Run by
- ObsEva SA
- People needed
- 526
- Starts
- 2017-04-20
- Expected to finish
- 2021-04-12
- Last updated by the study team
- 2021-06-09
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Site reference ID 169 — Dothan, Alabama, United States
- Site reference ID 353 — Mobile, Alabama, United States
- Site reference ID 232 — Vestavia Hills, Alabama, United States
- Site reference ID 242 — Phoenix, Arizona, United States
- Site reference ID 355 — Tucson, Arizona, United States
- Site reference ID 211 — Arcadia, California, United States
- Site reference ID 184 — Cerritos, California, United States
- Site reference ID 147 — Escondido, California, United States
- Site reference ID 154 — Huntington Park, California, United States
- Site reference ID 185 — Los Angeles, California, United States
- Site reference ID 199 — Northridge, California, United States
- Site reference ID 111 — Panorama City, California, United States
- Site reference ID 166 — Sacramento, California, United States
- Site reference ID 101 — San Diego, California, United States
- Site reference ID 239 — Upland, California, United States
- Site reference ID 112 — Westminster, California, United States
- Site reference ID 144 — Denver, Colorado, United States
- Site reference ID 246 — Englewood, Colorado, United States
- Site reference ID 234 — Thornton, Colorado, United States
- Site reference ID 189 — New Haven, Connecticut, United States
- Site reference ID 105 — Washington D.C., District of Columbia, United States
- Site reference ID 231 — Boca Raton, Florida, United States
- Site reference ID 190 — Boca Raton, Florida, United States
- Site reference ID 168 — Clearwater, Florida, United States
- Site reference ID 192 — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.